Cancer Medicines Forum workshop

Amsterdam, NL (Hybrid Event)

The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.

The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.

Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam

Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.

Next events

  • HTx proton therapy case study workshop

    Brussels, Belgium (hybrid)

  • EORTC Melanoma Group Autumn Meeting 2024

    Barcelona, Spain

  • CDDF-EORTC Workshop on Innovation and Access in Rare Cancers

    Amsterdam, NL (Hybrid Event)

  • EORTC Quality of Life Group Autumn Meeting 2024

    Innsbruck, Austria

  • EORTC Pathobiology Group Autumn Meeting 2024

    Virtual Event